Aims Chronic heart failure may lead to chronic kidney disease. Previous studies suggest
tubular markers N‐acetyl‐b‐D‐glucosaminidase (NAG) and Kidney‐injury‐molecule‐1 (KIM …

Aim Patients with chronic heart failure (CHF) are often characterized by the cardiorenal
syndrome (CRS). The aim of the present study was to assess whether novel markers of …

Aims Patients with chronic heart failure are often characterized by impaired renal function,
also referred to as cardiorenal syndrome (CRS). The aim of this study was to assess whether …

Aim: NAG and KIM-1 as markers of tubular damage are suggested as potential biomarkers
for the cardiorenal syndrome. The aim of the study was to assess the prognostic capability of …

Aim: The study focused on biomarkers of kidney injury as predictors of mortality in patients
with chronic heart failure (CHF) in a long-term follow-up (median 104 months) …

Over the preceding decade, the nephrology community has enjoyed success in the
development of urinary biomarkers that can predict the development of acute kidney injury …

Acute cardiorenal syndrome (CRS) corresponds to an association of acute heart failure and
a worsening of renal function. The detection of acute kidney injury (AKI) unfortunately occurs …

Aim Acute kidney injury (AKI) is often underdiagnosed due to several limitations of the renal
marker creatinine. Tubular urinary biomarkers may substantially contribute to diagnose AKI …

Objectives: This study sought to determine the relationship of KIM-1 levels with adverse
clinical outcomes in acute decompensated heart failure (ADHF). Background: Kidney injury …

Aims Urinary kidney injury molecule‐1 (KIM‐1) is a marker of tubular damage and
associated with worse outcome in heart failure (HF). Plasma KIM‐1 has not been described …